Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 8—August 2022
Research

Invasive Pneumococcal Disease and Long-Term Mortality Rates in Adults, Alberta, Canada

Kristen A. Versluys, Dean T. EurichComments to Author , Thomas J. Marrie, and Gregory J. Tyrrell
Author affiliations: University of Alberta, Edmonton, Alberta, Canada (K.A. Versluys, D.T. Eurich, G.T. Tyrrell); Dalhousie University, Halifax, Nova Scotia, Canada (T.J. Marrie); Provincial Laboratory for Public Health, Edmonton (G.T. Tyrrell)

Main Article

Table 3

Stratified hazard ratios for case-patients versus controls for invasive pneumococcal disease long-term mortality rates in adults, Alberta, Canada

Characteristic Hazard ratio (95% CI), p value
<30 d 30–90 d >90 d Overall
Age <45 y 8.88 (5.46‒14.42), <0.001 1.75 (0.88‒3.47), 0.110 2.41 (1.97‒2.95), <0.001 2.97 (2.49‒3.53), <0.001
Age 45–60 y 4.66 (3.56‒6.09), <0.001 1.44 (0.94‒2.21), 0.098 1.64 (1.43‒1.89), <0.001 2.02 (1.80‒2.27), <0.001
Age 60–75 y 3.85 (3.00‒4.95), <0.001 1.36 (0.92‒2.00), 0.127 1.36 (1.19‒1.55), <0.001 1.69 (1.51‒1.89), <0.001
Age >75 y
2.54 (2.05‒3.15), <0.001
1.79 (1.28‒2.50), 0.001
1.10 (0.97‒1.26), 0.137
1.41 (1.27‒1.56), <0.001
Male 3.57 (3.00‒4.25), <0.001 1.48 (1.12‒1.94), 0.005 1.40 (1.27‒1.54), <0.001 1.71 (1.58‒1.85), <0.001
Female
4.02 (3.29‒4.91), <0.001
1.71 (1.24‒2.35), 0.001
1.50 (1.34‒1.66), <0.001
1.86 (1.71‒2.04), <0.001
Elixhauser score 0–1 6.41 (4.01‒10.24), <0.001 16.73 (5.09‒55.06), <0.001 1.72 (1.47‒2.02), <0.001 2.16 (1.87‒2.49), <0.001
Elixhauser score >2 3.55 (3.10‒4.08), <0.001 1.32 (1.06‒1.65), 0.015 1.36 (1.26‒1.48), <0.001 1.70 (1.59‒1.81), <0.001

Main Article

Page created: July 11, 2022
Page updated: July 20, 2022
Page reviewed: July 20, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external